the Board of Directors (the “Board”) of STAAR Surgical Company (the “Company”) voted to increase the size of the Board from six (6) directors to eight (8) directors and appointed to the Board two new directors, Arthur Butcher and Wei Jiang, effective March 12, 2024.
director K. Peony Yu has indicated that she does not intend to stand for re-election to the Board upon the expiration of her term as a director at the Corporation’s 2024 Annual Meeting of Shareholders
the Board of Directors (the “Board”) of STAAR Surgical Company (the “Company”) voted to increase the size of the Board from six (6) directors to eight (8) directors and appointed to the Board two new directors, Arthur Butcher and Wei Jiang, effective March 12, 2024.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Arthur Butcher was appointed as Director at STAAR SURGICAL CO.
Action
appointed
Role
Director
Exact text from the filing
the Board of Directors (the “Board”) of STAAR Surgical Company (the “Company”) voted to increase the size of the Board from six (6) directors to eight (8) directors and appointed to the Board two new directors, Arthur Butcher and Wei Jiang, effective March 12, 2024.
K. Peony Yu departed as Director at STAAR SURGICAL CO.
Action
does not intend to stand for re-election
Role
Director
Exact text from the filing
director K. Peony Yu has indicated that she does not intend to stand for re-election to the Board upon the expiration of her term as a director at the Corporation’s 2024 Annual Meeting of Shareholders
Wei Jiang was appointed as Director at STAAR SURGICAL CO.
Action
appointed
Role
Director
Exact text from the filing
the Board of Directors (the “Board”) of STAAR Surgical Company (the “Company”) voted to increase the size of the Board from six (6) directors to eight (8) directors and appointed to the Board two new directors, Arthur Butcher and Wei Jiang, effective March 12, 2024.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.